PL359249A1 - Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego - Google Patents

Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego

Info

Publication number
PL359249A1
PL359249A1 PL35924903A PL35924903A PL359249A1 PL 359249 A1 PL359249 A1 PL 359249A1 PL 35924903 A PL35924903 A PL 35924903A PL 35924903 A PL35924903 A PL 35924903A PL 359249 A1 PL359249 A1 PL 359249A1
Authority
PL
Poland
Prior art keywords
oxoethyl
phenyl
amino
diacetic acid
derivatives
Prior art date
Application number
PL35924903A
Other languages
English (en)
Inventor
Elżbieta Olasik
Bolesław Karwowski
Małgorzata Witczak
Michał Studniarek
Original Assignee
Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny filed Critical Uniwersytet Medyczny
Priority to PL35924903A priority Critical patent/PL359249A1/pl
Priority to PCT/PL2004/000017 priority patent/WO2004082721A1/en
Publication of PL359249A1 publication Critical patent/PL359249A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PL35924903A 2003-03-20 2003-03-20 Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego PL359249A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL35924903A PL359249A1 (pl) 2003-03-20 2003-03-20 Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego
PCT/PL2004/000017 WO2004082721A1 (en) 2003-03-20 2004-03-12 Complexes of gd +3 gadolinium ions with derivatives of n-2- (2- (phenylamino) -2- oxoethyl) -n- (carboxymethyl) - glycine and method for obtaining these complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL35924903A PL359249A1 (pl) 2003-03-20 2003-03-20 Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego

Publications (1)

Publication Number Publication Date
PL359249A1 true PL359249A1 (pl) 2004-10-04

Family

ID=33029126

Family Applications (1)

Application Number Title Priority Date Filing Date
PL35924903A PL359249A1 (pl) 2003-03-20 2003-03-20 Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego

Country Status (2)

Country Link
PL (1) PL359249A1 (pl)
WO (1) WO2004082721A1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds

Also Published As

Publication number Publication date
WO2004082721A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
ATE442348T1 (de) Amino substituierte phenylessigsäuren sowie deren derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
ATE528288T1 (de) Anthranilsäureamide, verfahren zu ihrer herstellung, ihre verwendung als antiarrhythmika sowie pharmazeutische zubereitungen davon
NO20026252D0 (no) AZA-broforbundet - bicykliske aminosyrederivater som alfa 4 integrin antagonister
ATE260272T1 (de) Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
EP1261757A4 (en) ELECTRODE MATERIAL, DEVICE AND METHOD FOR DETECTING NITROGEN OXIDES
CY1108874T1 (el) ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ
EP1697308A4 (en) PHENYLAMID AND PYRIDYLAMIDE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
DE60210409D1 (de) Aripiprazole wirkstoff mit niedriger hygroskopie und verfahren zu ihrer herstellung
DE60219469D1 (de) Heterozyklische verbindungen, verfahren zu deren herstellung sowie deren verwendung als antibiotika
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
ATE241616T1 (de) Abgewandelte aminosäureamide als cgrp antagonisten
DE60110558D1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
ATE453624T1 (de) Kristallform von lercanipidin-hydrochlorid zur verwendung als antihypertensives mittel
ATE394394T1 (de) Arylvinylazacycloalkane verbindungen und methoden zu ihrer herstellung und deren verwendung
ITMI20000572A0 (it) Serratura per serramenti ad elevata flessibilita' di impiego
IS7609A (is) 2,5-tvíútskipt 3-merkaptópentansýra
FR2858345B1 (fr) Procede de renforcement d'un ouvrage d'art et piece d'ancrage associee
DE50206824D1 (de) Befestigungselement und verfahren zu seiner herstellung sowie verwendung
ZA200506750B (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluroanilino) phenylacetic acid
BR0316544A (pt) Compostos calcilìticos
PL359249A1 (pl) Nowe kompleksy jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego oraz sposób otrzymywania nowych kompleksów jonów gadolinu Gd+3 z pochodnymi kwasu 2,2'-(2-(R1, R2, R3, R4, R5-fenylo)amino)-2-oksoetylo))dioctowego
EP1406517A4 (en) CONCENTRATED, FROZEN LIQUID ENTIRE EGG AND PROCESS FOR MANUFACTURING THE SAME
ATE404545T1 (de) Acylaminothiazolderivate, verfahren zu deren herstellung und deren verwendung als inhibitoren der produktion von beta-amyloidpeptid
ATE519860T1 (de) Verwendung von ribozymen zur detektion ebenfalls vorhandener agenzien